{
  "schema_version": "0.1.0",
  "id": "fda-drug-shortage:atropine-sulfate-injection",
  "slug": "atropine-sulfate-injection",
  "title": "FDA shortage status: Atropine Sulfate Injection",
  "ingredient": "Atropine Sulfate Injection",
  "status": "current",
  "source_statuses": [
    "Current",
    "To Be Discontinued"
  ],
  "brand_names": [
    "ATROPINE SULFATE"
  ],
  "therapeutic_categories": [
    "Anesthesia",
    "Neurology",
    "Pediatric"
  ],
  "dosage_forms": [
    "Injection"
  ],
  "routes": [
    "ENDOTRACHEAL",
    "INTRAMEDULLARY",
    "INTRAMUSCULAR",
    "INTRAVENOUS",
    "SUBCUTANEOUS"
  ],
  "package_count": 21,
  "packages": [
    {
      "package_ndc": "16729-483-03",
      "product_ndc": "16729-483",
      "company_name": "Accord Healthcare Inc.",
      "manufacturer_name": "Accord Healthcare, Inc.,",
      "presentation": "Atropine Sulfate, Injection, .05 mg/1 mL (NDC 16729-483-03)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "01/01/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "16729-484-90",
      "product_ndc": "16729-483",
      "company_name": "Accord Healthcare Inc.",
      "manufacturer_name": "Accord Healthcare, Inc.,",
      "presentation": "Atropine Sulfate, Injection, .1 mg/1 mL (NDC 16729-484-90)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "01/01/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "16729-512-43",
      "product_ndc": "16729-512",
      "company_name": "Accord Healthcare Inc.",
      "manufacturer_name": "Accord Healthcare Inc.",
      "presentation": "Atropine Sulfate, Injection, .4 mg/1 mL (NDC 16729-512-43)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "ENDOTRACHEAL",
        "INTRAMEDULLARY",
        "INTRAMUSCULAR",
        "INTRAVENOUS",
        "SUBCUTANEOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "01/01/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "16729-525-08",
      "product_ndc": null,
      "company_name": "Accord Healthcare Inc.",
      "manufacturer_name": null,
      "presentation": "Atropine Sulfate, Injection, .4 mg/1 mL (NDC 16729-525-08)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [],
      "update_date": "08/17/2026",
      "initial_posting_date": "01/01/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "16729-484-45",
      "product_ndc": "16729-483",
      "company_name": "Accord Healthcare Inc.",
      "manufacturer_name": "Accord Healthcare, Inc.,",
      "presentation": "Atropine Sulfate, Injection, 0.1 mg/1 mL (NDC 16729-484-45)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "01/01/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "16729-526-08",
      "product_ndc": null,
      "company_name": "Accord Healthcare Inc.",
      "manufacturer_name": null,
      "presentation": "Atropine Sulfate, Injection, 1 mg/1 mL (NDC 16729-526-08)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [],
      "update_date": "08/17/2026",
      "initial_posting_date": "01/01/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0517-1004-25",
      "product_ndc": "0517-1001",
      "company_name": "American Regent, Inc.",
      "manufacturer_name": "American Regent, Inc.",
      "presentation": "Atropine Sulfate, Injection, .4 mg/1 mL (NDC 0517-1004-25)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "01/01/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0517-1001-25",
      "product_ndc": "0517-1001",
      "company_name": "American Regent, Inc.",
      "manufacturer_name": "American Regent, Inc.",
      "presentation": "Atropine Sulfate, Injection, 1 mg/1 mL (NDC 0517-1001-25)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "01/01/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "76329-3340-1",
      "product_ndc": "76329-3340",
      "company_name": "Amphastar Pharmaceuticals, Inc.",
      "manufacturer_name": "International Medication Systems, Limited",
      "presentation": "Atropine Sulfate, Injection, .1 mg/1 mL (NDC 76329-3340-1)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/18/2026",
      "initial_posting_date": "01/01/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-580-20",
      "product_ndc": "63323-580",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Atropine Sulfate, Injection, .4 mg/1 mL (NDC 63323-580-20)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "ENDOTRACHEAL",
        "INTRAMEDULLARY",
        "INTRAMUSCULAR",
        "INTRAVENOUS",
        "SUBCUTANEOUS"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "01/01/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0641-6251-10",
      "product_ndc": "0641-6251",
      "company_name": "Hikma Pharmaceuticals USA, Inc.",
      "manufacturer_name": "Hikma Pharmaceuticals USA Inc.",
      "presentation": "Atropine Sulfate, Injection, 0.4 mg/1 mL (NDC 0641-6251-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "ENDOTRACHEAL",
        "INTRAMEDULLARY",
        "INTRAMUSCULAR",
        "INTRAVENOUS",
        "SUBCUTANEOUS"
      ],
      "update_date": "08/13/2026",
      "initial_posting_date": "12/20/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-4910-34",
      "product_ndc": null,
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": null,
      "presentation": "Atropine Sulfate, Injection, (Adult) 0.5 mg/5 mL (0.1 mg/mL) LifeShield\u00ae ABBOJECT\u00ae Glass Syringe (20 G x 1 1/2) (NDC 0409-4910-34)\"",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [],
      "update_date": "08/07/2026",
      "initial_posting_date": "01/01/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-4910-34",
      "product_ndc": null,
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": null,
      "presentation": "Atropine Sulfate, Injection, (Adult) 0.5 mg/5 mL (0.1 mg/mL) LifeShield\u00ae ABBOJECT\u00ae Glass Syringe (20 G x 1 1/2) (NDC 0409-4910-34)\"",
      "availability": null,
      "dosage_form": "Injection",
      "routes": [],
      "update_date": "11/07/2025",
      "initial_posting_date": "11/07/2025",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-4911-34",
      "product_ndc": null,
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": null,
      "presentation": "Atropine Sulfate, Injection, (Adult)1 mg/10 mL (0.1 mg/mL) LifeShield\u00ae ABBOJECT\u00ae Glass Syringe (20 G x 1 1/2)  (NDC 0409-4911-34)\"",
      "availability": null,
      "dosage_form": "Injection",
      "routes": [],
      "update_date": "11/07/2025",
      "initial_posting_date": "11/07/2025",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-4911-34",
      "product_ndc": null,
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": null,
      "presentation": "Atropine Sulfate, Injection, (Adult)1 mg/10 mL (0.1 mg/mL) LifeShield\u00ae ABBOJECT\u00ae Glass Syringe (20 G x 1 1/2) (NDC 0409-4911-34)\"",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [],
      "update_date": "08/07/2026",
      "initial_posting_date": "01/01/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-9630-05",
      "product_ndc": "0409-1630",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Atropine Sulfate, Injection, 0.25 mg/5 mL (0.05 mg/mL) Syringes (NDC 0409-9630-05)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "01/01/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-1630-10",
      "product_ndc": "0409-1630",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (NDC 0409-1630-10)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "01/01/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "64253-400-91",
      "product_ndc": "64253-400",
      "company_name": "Medefil, Inc.",
      "manufacturer_name": "Medefil, Inc.",
      "presentation": "Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (NDC 64253-400-91)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "01/01/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "70069-481-10",
      "product_ndc": "70069-481",
      "company_name": "Somerset Therapeutics, LLC",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "presentation": "Atropine Sulfate, Injection, .4 mg/1 mL (NDC 70069-481-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "ENDOTRACHEAL",
        "INTRAMEDULLARY",
        "INTRAMUSCULAR",
        "INTRAVENOUS",
        "SUBCUTANEOUS"
      ],
      "update_date": "07/20/2026",
      "initial_posting_date": "01/01/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "70069-631-25",
      "product_ndc": "70069-631",
      "company_name": "Somerset Therapeutics, LLC",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "presentation": "Atropine Sulfate, Injection, .4 mg/1 mL (NDC 70069-631-25)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "07/20/2026",
      "initial_posting_date": "01/01/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "70069-641-25",
      "product_ndc": "70069-631",
      "company_name": "Somerset Therapeutics, LLC",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "presentation": "Atropine Sulfate, Injection, 1 mg/1 mL (NDC 70069-641-25)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "07/20/2026",
      "initial_posting_date": "01/01/2012",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    }
  ],
  "availability_counts": {
    "Available": 11,
    "Unavailable": 8
  },
  "initial_posting_date": "01/01/2012",
  "latest_source_update": "11/07/2025",
  "source_updated_at": "2026-08-22",
  "official_url": "https://api.fda.gov/drug/shortages.json",
  "source_name": "U.S. Food and Drug Administration openFDA Drug Shortages",
  "source_license_url": "https://open.fda.gov/license/",
  "retrieved_at": "2026-08-22T15:54:11+00:00",
  "unknowns": {
    "local_availability": "Unknown. FDA status is nationwide and is not local inventory.",
    "clinical_alternatives": "Not provided. CiteFacts does not publish treatment or substitution advice.",
    "resolution_date": "Unknown unless an FDA source row provides an update date."
  },
  "derivations": {
    "status": "current when a grouped FDA row has Current; otherwise it preserves the available FDA Resolved, Discontinuation, or not-current state.",
    "ingredient_page": "Grouped by FDA generic_name, falling back to openFDA.generic_name.",
    "availability_counts": "Count of non-empty FDA package availability values; it is not a claim about local supply."
  }
}